Study protocol for a multicentre randomised controlled trial: Safety, Tolerability, efficacy and quality of life Of a human recombinant alkaline Phosphatase in patients with sepsis-associated Acute Kidney Injury (STOP-AKI) - Peters, E; Mehta, R L; Murray, P T (BMJ Open, 2016)
, et al.